Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Gruppo Oncologico Italiano di Ricerca Clinica

2 clinical trials · 2 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Gruppo Oncologico Italiano di Ricerca Clinica

RECRUITINGNCT06548867

Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib

CABOGEN is a Observational, retrospective, multicenter study that will enroll patients with metastatic clear cell renal carcinoma (mccRCC) treated with cabozantinib after one or...

Sponsor: Gruppo Oncologico Italiano di Ricerca ClinicaEnrolling: 801 location
Metastatic Renal Cell Carcinoma
RECRUITINGPhase 3NCT04996017

Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)

This is a multicentric double-blind, placebo controlled, phase III trial. In this study, patients who underwent to a surgical resection of pleural mesothelioma and are without...

Sponsor: Gruppo Oncologico Italiano di Ricerca ClinicaEnrolling: 16219 locations
Mesotheliomas Pleural